Aripiprazole Tablet 15 mg (Aripiprazole)

Adult dose

Adults with schizophrenia: The recommended initial dose is 10 mg or 15 mg once daily, regardless of meals. The dose may be adjusted within the range of 10-30 mg once daily, and should not be increased before 2 weeks. Maintenance therapy involves administering 15 mg once daily for more than 3 months. Adults with bipolar disorder: The initial recommended dose is 15 mg once daily for both monotherapy and adjunctive therapy, and it may be increased up to 30 mg depending on clinical response.

Child dose

Adolescents with schizophrenia (ages 13-17): The recommended dose is 10 mg once daily, starting from an initial 2 mg, increased to 5 mg after 2 days, and then to 10 mg after another 2 days with further increases in 5 mg increments. 30 mg is

This medication may increase the risk of suicidal thoughts or behaviors in children, adolescents, and young adults with major depressive disorder or other psychiatric disorders. Therefore, when prescribing to patients in these age groups, the doctor must carefully assess the necessity and risks, and the patient and family should closely monitor for any suicidal tendencies or behavioral changes. This medication is not approved for the treatment of pediatric depression. Serious side effects known as neuroleptic malignant syndrome may occur while taking this medication, including symptoms such as high fever, muscle rigidity, altered mental status, and autonomic instability. If these symptoms occur, the medication should be discontinued immediately, and professional treatment and monitoring are necessary. Long-term use may result in tardive dyskinesia, an irreversible extrapyramidal syndrome. The risk is particularly high in the elderly and women, and if symptoms develop, consultation with a physician may be necessary to adjust the medication. The risk of cerebrovascular events such as stroke increases in elderly patients with dementia, and mortality rates may also be higher, so it is advisable not to use this medication in dementia patients. This medication may affect blood glucose control; therefore, patients with diabetes or those at risk for diabetes should regularly check and manage their blood glucose levels. There is a risk of venous thromboembolism; therefore, patients with risk factors for thrombosis should be closely monitored before and during the use of this medication. Patients with hypersensitivity to this medication or lactose intolerance should not be administered this medication. Caution is advised for patients with orthostatic hypotension, a history of seizures, or cognitive or motor impairment, as sedation or dizziness may occur, necessitating careful attention while driving or operating dangerous machinery. Thermoregulation may be impaired; therefore, caution is needed in hot environments or during strenuous exercise. Special attention is required for patients with dysphagia or those at high risk of aspiration pneumonia. While taking this medication, mental symptoms such as anxiety, agitation, aggression, impulsivity, and insomnia may arise, and if these symptoms are severe or develop suddenly, medical advice should be sought. Additionally, this medication should not be used for the treatment of attention-deficit/hyperactivity disorder (ADHD). Common side effects of this medication include nausea, vomiting, constipation, headache, dizziness, sedation, insomnia, anxiety, fatigue, changes in appetite, weight gain, extrapyramidal symptoms, etc., and consultation with a physician should be made if side effects occur.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain of oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes (jaundice), extremely high drowsiness, sudden and severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, urinary frequency

Mild side effects

• Nausea
• vomiting
• constipation
• headache
• dizziness
• akathisia
• anxiety
• insomnia
• restlessness
• sedation

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage maintains the medication's effectiveness and safety for use.

Appearance

Yellow round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle, (Export 30 tablets (10 tablets/PTP × 3))